Publication | Open Access

Adoptive transfer of allogeneic Epstein–Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boostsLMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma

Radiation OncologyCancer ImmunosurveillanceImmunologyTumor ImmunityHumoral ImmunityT Cell ImmunityAllogeneic Epstein–barr VirusAdoptive TransferEbv-related Nasopharyngeal CarcinomaImmunotherapyMedicineCell TransplantationViral ImmunityViral Oncology